Loading company…
ZioPharm Inc. is a New York biotechnology company developing cancer therapies using drug delivery systems and biologics.
ZioPharm Inc. is a biotechnology company based in New York that develops cancer therapies through drug delivery methods and biologics. It completed an IPO on December 4, 2009, raising USD 48 mn, and is led by CEOs Heidi Hagen and Kevin Boyle. In its most recent fiscal year it reported revenue of USD 10,000 and EBITDA of USD -4,810,000. The company is listed at the Public stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in